BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9610886)

  • 1. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more.
    Darland T; Heinricher MM; Grandy DK
    Trends Neurosci; 1998 May; 21(5):215-21. PubMed ID: 9610886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptin/orphanin FQ: role in nociceptive information processing.
    Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
    Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
    Meunier JC
    Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test.
    Wang JL; Zhu CB; Cao XD; Wu GC
    Regul Pept; 1999 Feb; 79(2-3):159-63. PubMed ID: 10100930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nociceptin/orphanin FQ: pain, stress and neural circuits.
    Heinricher MM
    Life Sci; 2005 Nov; 77(25):3127-32. PubMed ID: 15985270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?
    Zeilhofer HU; Calò G
    J Pharmacol Exp Ther; 2003 Aug; 306(2):423-9. PubMed ID: 12721334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain.
    Courteix C; Coudoré-Civiale MA; Privat AM; Pélissier T; Eschalier A; Fialip J
    Pain; 2004 Jul; 110(1-2):236-45. PubMed ID: 15275773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development.
    Wtorek K; Janecka A
    Chem Biodivers; 2021 Jan; 18(1):e2000871. PubMed ID: 33351271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nociceptin/orphanin FQ (N/OFQ)--the opioid, antiopioid or neuromodulator?].
    Kotlińska J; Rafalski P
    Postepy Hig Med Dosw (Online); 2004 Apr; 58():209-15. PubMed ID: 15114256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla.
    Heinricher MM; McGaraughty S; Grandy DK
    J Neurophysiol; 1997 Dec; 78(6):3351-8. PubMed ID: 9405549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptin/orphanin FQ: actions within the brain.
    Meis S
    Neuroscientist; 2003 Apr; 9(2):158-68. PubMed ID: 12708619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.
    Thompson AA; Liu W; Chun E; Katritch V; Wu H; Vardy E; Huang XP; Trapella C; Guerrini R; Calo G; Roth BL; Cherezov V; Stevens RC
    Nature; 2012 May; 485(7398):395-9. PubMed ID: 22596163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orphanin FQ/nociceptin: from neural circuitry to behavior.
    Heinricher MM
    Life Sci; 2003 Jun; 73(6):813-22. PubMed ID: 12801601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC; Calo' G
    Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
    Grisel JE; Farrier DE; Wilson SG; Mogil JS
    Eur J Pharmacol; 1998 Sep; 357(1):R1-3. PubMed ID: 9788779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP
    Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous opiates and behavior: 2012.
    Bodnar RJ
    Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y; Simpson-Durand CD; Standifer KM
    Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of co-administration of intrathecal nociceptin/orphanin FQ and opioid antagonists on formalin-induced pain in rats.
    Lee H
    Yonsei Med J; 2013 May; 54(3):763-71. PubMed ID: 23549827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.